Home The Word Brain	My Amedeo FAQ Privacy About
	C49 + CC Journal Club For more information, please refer to our special emails from April 13 and May 19.

Stem Cell Research

Free Subscription Articles published in Leuk Lymphoma Retrieve available abstracts of 18 articles: HTML format

Single Articles

May 2025
1. THORDARDOTTIR TH, Rodenbach RA, Brauer M, Hall AC, et al
   'A perfect match': how hematologists discuss donor options and risks with black and white patients considering allogeneic stem cell transplant.
   Leuk Lymphoma. 2025 May 7:1-10. doi: 10.1080/10428194.2025.2500625.
   PubMed     Abstract available
   
   
   
2. RAMACHANDRA N, Vegivinti CTR, Sahu S, Sanawar R, et al
   Transforming growth factor beta receptor type I (TGF-betaRI) kinase inhibitors IOA-359 and IOA-360 stimulate erythropoiesis in MDS.
   Leuk Lymphoma. 2025;66:920-929.
   PubMed     Abstract available
   
   
   April 2025
3. GOSHO K, Sadato D, Kato S, Toya T, et al
   Diamond-Blackfan anemia syndrome in an adult with RPS19 and DDX41 variants successfully treated with allogeneic stem cell transplantation: a case report.
   Leuk Lymphoma. 2025 Apr 2:1-4. doi: 10.1080/10428194.2025.2486432.
   PubMed    
   
   
   March 2025
4. BISCHOF L, Ussmann J, Platzbecker U, Jentzsch M, et al
   Allogeneic stem cell transplantation for MDS-clinical issues, choosing preparative regimens and outcome.
   Leuk Lymphoma. 2025 Mar 12:1-14. doi: 10.1080/10428194.2025.2476652.
   PubMed     Abstract available
   
   
   
5. TUCCI A, Re A, Pagani C, Marcheselli L, et al
   A phase 2 study of autologous stem cell transplantation as salvage therapy for older patients with aggressive B-cell lymphoma prospectively evaluated by comprehensive geriatric assessment: the FIL_RECANZ study.
   Leuk Lymphoma. 2025 Mar 8:1-9. doi: 10.1080/10428194.2025.2471499.
   PubMed     Abstract available
   
   
   February 2025
6. SUN Y, Liu N, Liu Y, Deng J, et al
   Isolated CNS B lymphoid/myeloid bilineage relapse following allogeneic hematopoietic stem cell transplantation in adult acute myeloid leukemia with KMT2A::MLLT1 rearrangement.
   Leuk Lymphoma. 2025 Feb 10:1-4. doi: 10.1080/10428194.2025.2460046.
   PubMed    
   
   
   December 2024
7. SHUMILOV E, Levien L, Mazzeo P, Jung W, et al
   Allogeneic stem cell transplantation against aggressive lymphomas: graft-versus-lymphoma effects in peripheral T-cell lymphoma and diffuse large B-cell lymphoma after myeloablative conditioning.
   Leuk Lymphoma. 2024 Dec 11:1-12. doi: 10.1080/10428194.2024.2438805.
   PubMed     Abstract available
   
   
   
8. PAISIOU A, OIkonomopoulou C, Pavlidis D, Ampatzidou M, et al
   CDKN2A/B deletion as an independent negative prognostic factor for allogeneic hematopoietic stem cell transplantation in childhood B cell precursor acute lymphoblastic leukemia.
   Leuk Lymphoma. 2024 Dec 1:1-4. doi: 10.1080/10428194.2024.2434177.
   PubMed    
   
   
   November 2024
9. LECORNEC N, Duchmann M, Itzykson R
   Single-cell sequencing applications in acute myeloid leukemia.
   Leuk Lymphoma. 2024 Nov 4:1-15. doi: 10.1080/10428194.2024.2422833.
   PubMed     Abstract available
   
   
   October 2024
10. DEHGHANI SS, Wang Y, Ramesh KH, Cooper D, et al
    Atypical chronic myeloid leukemia (CML) with ETV6-ABL1 mutation managed successfully with a third-generation TKI and hematopoietic stem cell transplant.
    Leuk Lymphoma. 2024 Oct 18:1-3. doi: 10.1080/10428194.2024.2403666.
    PubMed    
    
    
    August 2024
11. JEANSELME P, Tavitian S, Lapierre L, Vergez F, et al
    Long-term exposure and response to azacitidine for post-hematopoietic stem cell transplantation relapse of early T-cell precursor acute lymphoblastic leukemia: a case report and review of the literature.
    Leuk Lymphoma. 2024 Aug 14:1-6. doi: 10.1080/10428194.2024.2390572.
    PubMed     Abstract available
    
    
    July 2024
12. DALAL P, Dalal J
    PTCy-ATG mutually exclusive or additive? Anti-thymocyte globulin combined with post-transplantation cyclophosphamide reduce graft-versus-host disease in hematopoietic stem cell transplantation for pediatric leukemia.
    Leuk Lymphoma. 2024 Jul 31:1-2. doi: 10.1080/10428194.2024.2379976.
    PubMed    
    
    
    
13. TARANTINI F, Cumbo C, Anelli L, Zagaria A, et al
    Venetoclax-based treatment in acute myeloid leukemia: an unexpected bonus on the path to allogeneic hematopoietic stem cell transplant?
    Leuk Lymphoma. 2024 Jul 23:1-12. doi: 10.1080/10428194.2024.2381649.
    PubMed     Abstract available
    
    
    
14. HU M, Li J, Hu T, Zhang Z, et al
    Anti-thymocyte globulin combined with post-transplantation cyclophosphamide reduce graft-versus-host disease in hematopoietic stem cell transplantation for pediatric leukemia.
    Leuk Lymphoma. 2024 Jul 7:1-10. doi: 10.1080/10428194.2024.2376179.
    PubMed     Abstract available
    
    
    
15. STEWART C, Owen C, Chua N, Peters A, et al
    Importance of long-term follow-up of autologous stem cell transplantation for mantle cell lymphoma.
    Leuk Lymphoma. 2024 Jul 5:1-4. doi: 10.1080/10428194.2024.2373323.
    PubMed    
    
    
    June 2024
16. JIANG J, Sigmund AM, Zhao Q, Elder P, et al
    Impact of chronic graft-versus-host disease on non-relapse mortality and survival.
    Leuk Lymphoma. 2024 Jun 12:1-8. doi: 10.1080/10428194.2024.2365910.
    PubMed     Abstract available
    
    
    May 2024
17. NAGAYAMA T, Fujiwara SI, Tominaga R, Yokoyama D, et al
    Association of the pre-transplant CD4/CD8 ratio with the prognosis following allogeneic hematopoietic stem cell transplantation.
    Leuk Lymphoma. 2024 May 20:1-7. doi: 10.1080/10428194.2024.2352614.
    PubMed     Abstract available
    
    
    
18. VON DEM BORNE PA, Kemps-Mols BM, de Wreede LC, van Beek AA, et al
    The degree of HLA matching determines the incidence of cytokine release syndrome and associated nonrelapse mortality in matched related and unrelated allogeneic stem cell transplantation with post-transplant cyclophosphamide.
    Leuk Lymphoma. 2024 May 6:1-11. doi: 10.1080/10428194.2024.2344060.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Stem Cell Research is free of charge.